Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03667859
Other study ID # 0398-18-RMB
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2018
Est. completion date August 31, 2020

Study information

Verified date September 2020
Source Rambam Health Care Campus
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Female patients with either uterine/cervical malignancies will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after radiation treatment.


Description:

Patients will be recruited and sign a consent form. The patients included are patients with either uterine/cervical malignancies. Each participant undergoes radiation treatment either as primary or complementary treatment.

Assessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different points:

- Before the first treatment session (baseline).

- After the last session of laser treatment.

- 3 months post final treatment. Every patient will serve as her own control. Demographic, gynecologic and obstetric history will be obtained from patients' electronic files.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date August 31, 2020
Est. primary completion date July 31, 2020
Accepts healthy volunteers
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Any woman undergoing either brachytherapy or pelvic radiation treatment as primary or complementary treatment for a cervical/uterine malignancy.

Exclusion Criteria:

- Women that are not in the age range.

- Women with massive vaginal bleeding.

- Women after pelvic exenteration.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Vaginal Tactile Imaging
Vaginal elasticity measurements using the Vaginal Tactile Imaging system.

Locations

Country Name City State
Israel Rambam health care campus Haifa

Sponsors (1)

Lead Sponsor Collaborator
Rambam Health Care Campus

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vaginal elasticity assessment Vaginal elasticity as measured by the vaginal tactile imager. up to 6 months from enrollment
See also
  Status Clinical Trial Phase
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3
Completed NCT02985164 - Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography Phase 3
Recruiting NCT04152681 - Effect and Safety of Apatinib on Radiation-Induced Brain Injury Phase 2
Recruiting NCT04818099 - Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy Phase 3
Terminated NCT03660618 - LSFG-SKIN, Laser Speckle Flowgraphy N/A
Completed NCT00725244 - Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias Phase 4
Completed NCT00001523 - Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation N/A
Recruiting NCT03907371 - The Effect of Donepezil in Radiotherapy-related Cognitive Impairment. Phase 2
Not yet recruiting NCT05063773 - Novel Wireless Mixed Reality Headset for Image Guidance in Cardiac Catheterization Laboratory N/A
Completed NCT00001437 - Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis Phase 2
Recruiting NCT06325982 - Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury N/A
Recruiting NCT03208413 - The Therapeutic Effect of Thalidomide in RI Phase 2
Completed NCT02972736 - RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study
Completed NCT02104271 - Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial. Phase 2
Terminated NCT00134628 - Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries Phase 3
Completed NCT03961217 - Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes